Global Custom Market Research Reports Provider Company

phone

Cellect Biotechnology Ltd (APOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 36
  • Category: Pharmaceuticals
  • Country: Israel
Summary

Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The companys technology platform is developing ApoGraft solutions which provides functional selection of stem and progenitor cells through an apoptotic process with focus on hematopoietic cells field. It is developing ApoTainer selection kit, a off-the-shelf medical device product for use in bone marrow transplantation, immune disorders and organ transplantations. The company offers licensing opportunities to pharmaceutical companies, medical research centers, academies and hospitals with the tools to rapidly isolate stem cells and allow stem cell related treatments and procedures. Cellect Biotechnology is headquartered in Kfar Saba, Israel.

Cellect Biotechnology Ltd (APOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 11
Accellta Enters into Agreement with Cellect Biomed 12
Equity Offering 13
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 13
Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 14
Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 16
Cellect Biotech Raises Funds through Private Placement of Shares 17
Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 18
Cellect Biotech to Raise USD1 Million in Private Placement of Shares 19
Cellect Biotechnology Ltd - Key Competitors 20
Cellect Biotechnology Ltd - Key Employees 21
Cellect Biotechnology Ltd - Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Mar 19, 2018: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results 23
May 29, 2017: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2017 Financial Results 25
Corporate Communications 26
Oct 19, 2017: Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer 26
Jun 09, 2017: Cellect is Moving to Trade Exclusively on the NASDAQ 27
Feb 23, 2017: World-Renowned Stem Cell Transplantation Expert joins Cellects Advisory Board 28
Feb 14, 2017: Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange 29
Product News 30
03/27/2017: Cellect Announces Successful First Cancer Patient Stem Cell Transplant 30
02/21/2017: Cellect Announces Positive Clinical Trial Results 31
02/08/2017: First Cancer Patient Treated In Phase I/II Trial of ApoGraft 32
Product Approvals 33
Sep 05, 2017: FDA Grants Orphan Drug Status to Cellects ApoGraft for Acute GvHD and Chronic GvHD 33
May 03, 2017: Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S. 34
Other Significant Developments 35
Apr 09, 2018: Cellect Announces a Major Milestone for Enabling Stem Cells Production 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables

List of Tables
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cellect Biotech Enters into Agreement with Hadasit Medical Research Services & Development 11
Accellta Enters into Agreement with Cellect Biomed 12
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 13
Cellect Biotech Raises USD4.3 Million in Private Placement of American Depositary Shares 14
Cellect Biotech Raises Funds through Private Placement of Shares upon Exercise of Warrants 16
Cellect Biotech Raises Funds through Private Placement of Shares 17
Cellect Biotech Raises USD4.3 Million in Private Placement of Shares 18
Cellect Biotech to Raise USD1 Million in Private Placement of Shares 19
Cellect Biotechnology Ltd, Key Competitors 20
Cellect Biotechnology Ltd, Key Employees 21

List Of Figures

List of Figures
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in

View Report

Cellectar Biosciences Inc (Cellectar) is a pharmaceutical company that undertakes the development of phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is

View Report

Cellectis SA (Cellectis) is a biopharmaceutical company that specializes in the research, development and commercialization of rational genome engineering technologies. The company develops treatment based on allogeneic T-cell for the

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports